{"id":"https://openalex.org/A5073726268","orcid":null,"observed_orcids":[],"display_name":"Mark J. Elzey","raw_author_names":["Mark J Elzey","Mark J. Elzey"],"full_name":"Mark J. Elzey","works_count":5,"cited_by_count":224,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":5,"i10_index":5},"ids":{"openalex":"https://openalex.org/A5073726268","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I184840846","ror":"https://ror.org/02nkdxk79","display_name":"Virginia Commonwealth University","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},"years":[2003,2002]},{"institution":{"id":"https://openalex.org/I4210133499","ror":"https://ror.org/04b885n69","display_name":"Kal\u00e9o (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133499"]},"years":[2016]}],"last_known_institutions":[{"id":"https://openalex.org/I4210133499","ror":"https://ror.org/04b885n69","display_name":"Kal\u00e9o (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133499"]}],"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","count":3,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","count":3,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","count":2,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","count":2,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","count":2,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","value":1.5e-05,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","value":1.41e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","value":5.9e-06,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","value":5.8e-06,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","value":5.8e-06,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.902026891708374},{"id":"2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","score":0.8670550584793091},{"id":"2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","score":0.6688048243522644},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.2934173345565796},{"id":"170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","score":0.20972296595573425}],"counts_by_year":[{"year":2002,"works_count":1,"oa_works_count":0,"cited_by_count":52},{"year":2003,"works_count":1,"oa_works_count":0,"cited_by_count":53},{"year":2016,"works_count":3,"oa_works_count":1,"cited_by_count":119}],"display_name_alternatives":["Mark J Elzey","Mark J. Elzey"],"block_key":"m elzey","works_api_url":"https://api.openalex.org/works?filter=author.id:A5073726268","updated_date":"2026-10-10T12:59:14","created_date":"2025-10-10T00:00:00"}